Agranulocytosis secondary to cancer chemotherapy 1 D70.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM D70.1 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of D70.1 - other international versions of ICD-10 D70.1 may differ.
cytoreductive cancer chemotherapy sequela D70.1 Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
neutropenic splenomegaly (D73.81); transient neonatal neutropenia (P61.5); agranulocytosis; decreased absolute neurophile count (ANC); code for any associated:; fever (R50.81); mucositis (J34.81, K12.3-, K92.81, N76.81) D70.1 Agranulocytosis secondary to cancer chemother...
ICD-10 code D70. 9 for Neutropenia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
ICD-10 Code ICD-10 Description Assign when immunodeficiency is due to: D84. 821 Immunodeficiency due to drugs Medications that interfere with the immune system. These medications include immunosuppressants, corticosteroids, and chemotherapy.
1 for Encounter for antineoplastic chemotherapy and immunotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.
People with immunodeficiency or autoimmune disease are considered immunocompromised, but other factors can also cause someone to be immunocompromised, such as cancer, cancer treatments, metabolic disorders or advanced age, according to The University of Texas MD Anderson Cancer Center.
D84. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D84.
If a patient admission/encounter is solely for the administration of chemotherapy, immunotherapy or external beam radiation therapy assign code Z51. 0, Encounter for antineoplastic radiation therapy, or Z51. 11, Encounter for antineoplastic chemotherapy, or Z51.
Code 96413 (chemotherapy administration, intravenous infusion technique; up to one hour, single or initial substance/drug) would be used to report the first 90 minutes of the infusion.
ICD-10 Code for Other long term (current) drug therapy- Z79. 899- Codify by AAPC.
Cytotoxic chemotherapy for the treatment of cancer causes a range of side effects that adversely affect patient health and quality of life. One such side effect is myelosuppression, where chemotherapy massively depletes bone marrow progenitor cells resulting in anemia, neutropenia, and thrombocytopenia (1–3).
Antineoplastic drugs are medications used to treat cancer. Other names for antineoplastic drugs are anticancer, chemotherapy, chemo, cytotoxic, or hazardous drugs.
Breast Cancer ICD-10 Code Reference SheetFEMALERightC50.811Malignant neoplasm of overlapping sites, right female breastC50.911Malignant neoplasm of unspecified site, right female breastD05.01Lobular carcinoma in situ, right breast9 more rows